Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Other 4Thoracic 3Other solid neoplasm 3Lymphoid 3Tumor-Agnostic 2Other neoplasm 2Gynecologic 2Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Lung Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mindfulness-Based Stress Reduction × Genitourinary × Clear all
NCT02783079 2016-05-26

Insomnia Interventions in Cancer Survivors

The Cooper Health System

Phase NA Unknown
210 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Sleep Initiation and Maintenance Disorders, Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡